Stockreport

Axcella Announces Positive Interim Findings from Ongoing Clinical Study of AXA1125/AXA1957 in Subjects with NAFLD and Expected 2020 Milestones

Axcella Health Inc.  (AXLA) 
Last axcella health inc. earnings: 3/23 04:01 pm Check Earnings Report
PDF Multifactorial liver and systemic biological activity seen for both AXA1125 and AXA1957 in adult subjects with NAFLD at 16 weeks with onset as early as eight weeksInteri [Read more]